Part II: From Ideas to a Better World: Patenting & Licensing Inventions

UNC is dedicated to promoting research – including research that has practical applications for improving society. The University fosters that research through a process that turns ideas into positive end-products.

The 1990s witnessed an impressive increase in invention disclosures, patenting and licensing. This trend is expected to continue through the new millennium.

The Corporate Partnership

Corporate funding plays an important role in sponsoring research at UNC-CH. Corporate support has been on the increase through the 1990s, accounting for 6% of total research funding in 1998.

While all inventions developed at the University remain intellectual property of UNC-CH, corporations that fund research generally have the first option of licensing the resulting inventions.

Statistics courtesy of the UNC Office of Technology Development and the Office of Information and Communications.

- Andrew Leiter

Bayer Corporation
Boston Biomedica, Inc.
Bristol-Myers Squibb
Cell Genesys, Inc.
Cytogen Corporation
Du Pont-Merck Pharmaceuticals
E.I. Du Pont de Nemours
Genentech, Inc.

Genzyme Corporation
Glaxo-Wellcome, Inc.
Hewlett Packard
Hoescht Marion Roussel, Inc.
Inspire Pharmaceuticals, Inc.
Merck & Co., Inc.
Novartis
Oxford Biomedica (UK) Limited

© 2002, The Graduate School, The University of North Carolina at Chapel Hill
All text and images are property of The Graduate School at the University of North Carolina-Chapel Hill. Contact Sandra Hoeflich at shoeflic@email.unc.edu to request permission for reproduction.

Contact Alexandra Obregon at aobregon@email.unc.edu if you have technical problems with this Web site.